Actinomycetes of the genus Rhodococcus (class Actinomycetia) are dominant dwellers of biotopes with anthropogenic load. They serve as a natural system of primary response to xenobiotics in open ecosystems, initiate defensive responses in the presence of pollutants, and are regarded as ideal agents capable of transforming and degrading pharmaceuticals. Here, the ability of selected Rhodococcus strains to co-metabolize nonsteroidal anti-inflammatory drugs (ibuprofen, meloxicam, and naproxen) and information on the protective mechanisms of rhodococci against toxic effects of pharmaceuticals, individually or in a mixture, have been demonstrated. For the first time, R. ruber IEGM 439 provided complete decomposition of 100 mg/L meloxicam after seven days. It was shown that versatile cellular modifications occurring at the early development stages of nonspecific reactions of Rhodococcus spp. in response to separate and combined effects of the tested pharmaceuticals included changes in electrokinetic characteristics and catalase activity; transition from unicellular to multicellular life forms accompanied by pronounced morphological abnormalities; changes in the average size of vegetative cells and surface area-to-volume ratio; and the formation of linked cell assemblages. The obtained data are considered as adaptation mechanisms in rhodococci, and consequently their increased resistance to separate and combined effects of ibuprofen, meloxicam, and naproxen.
23 July 2025 in Frontiers in Bioengineering and Biotechnology
Introduction: Pharmaceutical contaminants such as meloxicam pose significant environmental risks due to their persistence and toxicity. The biodegradation potential of actinomycetes, particularly representatives of Gordonia, offers promising avenues for eco-friendly wastewater treatment. However, the ability of Gordonia to fully degrade meloxicam has not been previously demonstrated.Methods: The biodegradation of meloxicam was investigated using G. alkanivorans IEGM 1277 as a model organism. Metabolite identification was performed using liquid chromatography-mass spectrometry (LC-MS). Candidate genes encoding meloxicam-oxidising enzymes were identified via genomic analysis. Adaptive bacterial responses to meloxicam exposure were characterised using atomic force microscopy (AFM), transmission electron microscopy (TEM), and energy-dispersive X-ray spectroscopy (EDX).Results: G. alkanivorans IEGM 1277 successfully decomposed meloxicam into primary metabolites, 5'-hydroxymethyl- and 5'-carboxymeloxicam, which exhibited reduced (eco)toxicity compared to the parent compound. Genomic analysis revealed several candidate genes potentially involved in meloxicam oxidation. Microscopic and spectroscopic analyses demonstrated significant phenotypic and metabolic changes in bacterial cells, indicating adaptive defence mechanisms triggered by meloxicam exposure.Discussion: This study provides the first evidence of complete meloxicam biodegradation by Gordonia and elucidates the underlying enzymatic and adaptive cellular responses. The findings highlight the potential application of G. alkanivorans IEGM 1277 in developing efficient and environmentally safe biotechnologies for pharmaceutical wastewater treatment.
Meloxicam, a selective cyclooxygenase-2 inhibitor, is commonly used as non-steroidal anti-inflammatory drug in both human and veterinary medicine. Owing to its heterocyclic structure, toxicity to invertebrates, vertebrates, and microorganisms, and potential to biomagnify through the food webs, meloxicam persists in the environment and poses a risk to ecological health. There is still a paucity of information on meloxicam as a pharmaceutical contaminant. It is not included in priority lists, which means its environmental risk is often underestimated. This paper provides an integrative overview of the currently available literature (2009–2026) on the environmental occurrences, ecotoxicity, transport pathways, and removal strategies of meloxicam. The distribution of meloxicam has been most extensively studied in aquatic environments, whereas information on soils, plants, and terrestrial fauna remains limited. Bioaugmentation is the most promising strategy for reducing ecotoxicological risk, although its effectiveness against meloxicam has so far been confirmed only in a few model systems. The evidence presented here underscores the importance of strict regulation of meloxicam use and routine environmental monitoring. We hope this review will be useful to ecologists, microbiologists, and regulatory agencies developing strategies to mitigate pharmaceutical contamination.
20 July 2025 in Problems of Biological, Medical and Pharmaceutical Chemistry
Introduction. In connection with the development of agricultural and medicinal plant growing, the search for effective biostimulants is relevant. The results of long-term research by the authors showed that the product of paracetamol biodegradation, obtained from paracetamol waste by biotechno-logical means, is an active stimulator of plant growth and an inducer of accumulation of biologically active substances in them. The aim of this study is to investigate the effect of paracetamol biodegradation product and hydrothermal conditions of vegetation periods of differ-ent years on the dynamics of phylloquinone (vitamin K1) accumulation in leaves of Urtica dioica L. Material and methods. The work used the biodegradation product of paracetamol as a biostimulator, and the plant growth stimulator drug "Zircon" as a reference when conducting field experiments in places of natural growth of nettles in the Perm Territory in 2022 and 2023. In the plant raw materi-als collected from the experimental and control sites at the beginning and end of the vegetation phase, the phylloquinone content was determined by high-performance liquid chromatography. The hydrothermal coefficient was used to assess the effect of hydrothermal conditions of the growing sea-son on the accumulation of phylloquinone. Results. Under the influence of the biostimulator used in the work, the phylloquinone content in nettle leaves at the beginning of the 2022 vegetation phase increased by 12.0% compared to the control, by 26.6% at the end of the phase, and by 2.6% and 9.1%, respectively, when treated with Zircon. The increase in phylloquinone content at the beginning and at the end of the 2023 vegetation phase under the influence of PBP was 1.5% and 6.5%, and when treated with Zircon – 0.4% and 0.6%, respectively. More favorable hydrothermal conditions compared to 2023 contributed to greater accu-mulation of phylloquinone in the control and experimental samples of 2022. Conclusion. The product of paracetamol biodegradation showed properties of an inducer of phylloquinone accumulation in stinging nettle leaves. A significant effect of hydrothermal conditions of the growing environment on the accumulation of phylloquinone by this plant in the vegetation periods of different years was shown.
Non-pathogenic actinomycetes play a key role in the degradation of xenobiotics and the biotransformation of complex organic compounds. Studying gene expression in these bacteria can be challenging due to the rigid cell wall that hinders RNA extraction. Here we present the first comprehensive study of total RNA isolation from Rhodococcus and Gordonia genera, encompassing 21 strains grown under 34 conditions, including n-alkanes C3–C16, terpenoids, non-steroidal anti-inflammatory drugs, used frying oil, and mercury chloride. We compared no lysis strategy and three cell lysis approaches (freezing-thawing, bead beating, and lysozyme treatment) combined with the TRIzol or silica column-based RNA extraction kits. Bead beating, despite aggressive mechanical action, failed to reliably yield intact RNA. We show for the first time that 40 mg/mL of lysozyme with prolonged exposure (1 h) reliably lyses Rhodococcus and Gordonia cells (96–100% successful isolations), yielding pure integral RNA (118.5–485.8 ng/µL) with the RNA Solo Kit, without requiring detergents. We also developed the first protocol for RNA extraction from Rhodococcus cells grown on used frying oil, requiring pre-washing with 0.1 vol.% Tween 80 to disintegrate hard-to-harvest aggregates. These findings establish a robust strategy for RNA isolation from hydrophobic Rhodococcus and Gordonia bacteria.
11 December 2025 in Microbiology Resource Announcements
We report the draft genome sequence of Gordonia alkanivorans IEGM 1277, an actinomycete strain exhibiting a pronounced ability to degrade the pharmaceutical pollutant meloxicam—an emerging environmental contaminant. Utilizing the acquired sequence, identify candidate genes that encode enzymes implicated in the degradation of meloxicam.